{"code":"E88.82","type":"code","title":"Obesity due to disruption of MC4R pathway","codeAlso":[],"includes":[],"modern_v":"official26","codeFirst":[],"excludes1":["histiocytosis X (chronic) (C96.6)","androgen insensitivity syndrome (E34.5-)","congenital adrenal hyperplasia (E25.0)","hemolytic anemias attributable to enzyme disorders (D55.-)","Marfan syndrome (Q87.4-)","5-alpha-reductase deficiency (E29.1)"],"excludes2":["Ehlers-Danlos syndromes (Q79.6-)"],"isBillable":true,"fyEffectivity":{"fy2026":true,"fy2027":true,"billableFy2026":true,"billableFy2027":true},"sibling_codes":["E88","E88.0","E88.01","E88.02","E88.09","E88.1","E88.10","E88.11","E88.12","E88.13","E88.14","E88.19","E88.2","E88.3","E88.4","E88.40","E88.41","E88.42","E88.43","E88.49","E88.8","E88.81","E88.810","E88.811","E88.818","E88.819","E88.89","E88.9","E88.A"],"inclusionTerms":[],"sibling_titles":{"code":"E88.A","title":"Wasting disease (syndrome) due to underlying condition","isBillable":true},"useAdditionalCode":["code, if applicable, to identify associated manifestations, such as polyphagia (R63.2)","code to identify body mass index (BMI), if known (Z68.-)","codes for associated conditions"],"clinicalDefinition":"Obesity due to disruption of MC4R pathway is a billable ICD-10-CM diagnosis code (E88.82). Excludes1 (not coded here): histiocytosis X (chronic) (C96.6); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.0); hemolytic anemias attributable to enzyme disorders (D55.-); Marfan syndrome (Q87.4-); 5-alpha-reductase deficiency (E29.1). Excludes2 (not included here): Ehlers-Danlos syndromes (Q79.6-).","officialDefinition":"Obesity due to disruption of MC4R pathway is a billable ICD-10-CM diagnosis code (E88.82). Excludes1 (not coded here): histiocytosis X (chronic) (C96.6); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.0); hemolytic anemias attributable to enzyme disorders (D55.-); Marfan syndrome (Q87.4-); 5-alpha-reductase deficiency (E29.1). Excludes2 (not included here): Ehlers-Danlos syndromes (Q79.6-). Use additional code: code, if applicable, to identify associated manifestations, such as polyphagia (R63.2); code to identify body mass index (BMI), if known (Z68.-); codes for associated conditions.","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}